{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:44:18Z","timestamp":1768538658764,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.jash.2007.01.010","type":"journal-article","created":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T14:01:47Z","timestamp":1180620107000},"page":"178-184","source":"Crossref","is-referenced-by-count":29,"title":["Chronic kidney disease and cardiovascular risk"],"prefix":"10.1016","volume":"1","author":[{"given":"Preethi","family":"Yerram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poorna R.","family":"Karuparthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hesemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Horst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Whaley-Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2007.01.010_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.279.8.585","volume":"279","author":"Fried","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2007.01.010_bib2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jash.2007.01.010_bib3","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.161.6.886","article-title":"High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension","volume":"161","author":"Schillaci","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2007.01.010_bib4","doi-asserted-by":"crossref","first-page":"I80","DOI":"10.1161\/01.HYP.13.5_Suppl.I80","article-title":"Prognostic value of serum creatinine and effect of treatment of hypertension on renal function","volume":"13","author":"Shulman","year":"1989","journal-title":"Hypertension"},{"issue":"Suppl 87","key":"10.1016\/j.jash.2007.01.010_bib5","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1046\/j.1523-1755.64.s87.5.x","article-title":"Chronic kidney disease and cardiovascular disease in the Medicare population","volume":"64","author":"Collins","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2007.01.010_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(03)00916-8","article-title":"A population-based study of the incidence and outcomes of diagnosed chronic kidney disease","volume":"42","author":"Drey","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2007.01.010_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0272-6386(98)70145-3","article-title":"Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here?","volume":"32","author":"Levey","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"5 Suppl 3","key":"10.1016\/j.jash.2007.01.010_bib8","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2007.01.010_bib9","series-title":"Harrison\u2019s Principles of Internal Medicine","first-page":"1653","author":"Kasper","year":"2005"},{"key":"10.1016\/j.jash.2007.01.010_bib10","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2007.01.010_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2215\/CJN.00730805","article-title":"Kidney-heart interactions: epidemiology, pathogenesis, and treatment","volume":"1","author":"Berl","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jash.2007.01.010_bib12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"4 Suppl 1","key":"10.1016\/j.jash.2007.01.010_bib13","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/S0272-6386(00)70239-3","article-title":"Cardiovascular disease and chronic renal disease: a new paradigm","volume":"35","author":"Sarnak","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2007.01.010_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1525-139X.2003.160301.x","article-title":"Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease","volume":"16","author":"Block","year":"2003","journal-title":"Semin Dial"},{"key":"10.1016\/j.jash.2007.01.010_bib15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults findings from The Third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2007.01.010_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in U.S. adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jash.2007.01.010_bib17","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1016\/j.annepidem.2004.01.002","volume":"14","author":"Muntner","year":"2004","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jash.2007.01.010_bib18","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1681\/ASN.2005010106","article-title":"Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults","volume":"16","author":"Kurella","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jash.2007.01.010_bib19","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00125-005-1876-2","article-title":"The metabolic syndrome: time for a critical appraisal","volume":"48","author":"Kahn","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jash.2007.01.010_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency","volume":"107","author":"Shlipak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2007.01.010_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease","volume":"28","author":"Foley","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2007.01.010_bib22","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1046\/j.1523-1755.2003.00932.x","article-title":"Aortic pulse wave velocity index and mortality in end-stage renal disease","volume":"63","author":"Blacher","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2007.01.010_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2007.01.010_bib24","doi-asserted-by":"crossref","first-page":"e10\u2013e17.","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jash.2007.01.010_bib25","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","article-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","volume":"15","author":"Guerin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jash.2007.01.010_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00041552-200303000-00002","article-title":"Anaemia, cardiovascular disease and kidney disease: integrating new knowledge in 2002","volume":"12","author":"Stevens","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jash.2007.01.010_bib27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0272-6386(97)90335-8","article-title":"Cardiovascular effects of recombinant human erythropoietin in predialysis patients","volume":"29","author":"Portoles","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2007.01.010_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.01.010_bib29","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1046\/j.1523-1755.2000.00289.x","article-title":"Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy","volume":"58","author":"Foley","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2007.01.010_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00019501-199003000-00010","article-title":"Homocyst(e)inemia in daily practice: levels in coronary heart disease","volume":"1","author":"Malinow","year":"1990","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jash.2007.01.010_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ki.1997.298","article-title":"Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcome","volume":"52","author":"Boston","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2007.01.010_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1523-1755.2001.059002407.x","article-title":"End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?","volume":"59","author":"Arici","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2007.01.010_bib33","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.01.010_bib34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.ajkd.2003.11.011","article-title":"Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients","volume":"43","author":"Varagunam","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2007.01.010_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/089686089801800407","article-title":"Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients","volume":"18","author":"Noh","year":"1998","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.jash.2007.01.010_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.290.3.353","article-title":"Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis","volume":"290","author":"Defilipp","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2007.01.010_bib37","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/01.ASN.0000128966.55133.69","article-title":"Kidney dysfunction, inflammation, and coronary events: a Prospective Study","volume":"15","author":"Knight","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jash.2007.01.010_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000014379","article-title":"Biological effects of oxidant stress in haemodialysis: the possible roles of vitamin E","volume":"17","author":"Galli","year":"1999","journal-title":"Blood Purif"},{"key":"10.1016\/j.jash.2007.01.010_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.jash.2007.01.010_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jash.2007.01.010_bib41","first-page":"155A","article-title":"A simplified equation to predict glomerular filtration rate from serum creatinine","volume":"11","author":"Levey","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jash.2007.01.010_bib42","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0272-6386(99)70442-7","article-title":"Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation","volume":"33","author":"Keane","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2007.01.010_bib43","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM199811123392007","article-title":"Pathophysiology of progressive nephropathies","volume":"339","author":"Remuzzi","year":"1998","journal-title":"N Engl J Med"},{"issue":"25 Suppl 1","key":"10.1016\/j.jash.2007.01.010_bib44","first-page":"31","article-title":"Surrogate markers for cardiovascular disease: functional markers","volume":"109","author":"Cohn","year":"2004","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.jash.2007.01.010_bib45","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2007.01.010_bib46","first-page":"S1","article-title":"Clinical practice recommendations","volume":"24","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2007.01.010_bib47","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1681\/ASN.V76930","article-title":"Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin\/creatinine ratio","volume":"7","author":"Warram","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jash.2007.01.010_bib48","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/01.ATV.19.8.1992","article-title":"Urinary albumin excretion","volume":"19","author":"Borch-Johnsen","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 1","key":"10.1016\/j.jash.2007.01.010_bib49","first-page":"S79","article-title":"ADA position statement: nephropathy in diabetes","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2007.01.010_bib50","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2007.01.010_bib51","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.01.010_bib52","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.01.010_bib53","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.amjhyper.2004.11.017","article-title":"The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease","volume":"18","author":"Weir","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2007.01.010_bib54","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.amjhyper.2004.11.018","article-title":"Preventing chronic kidney disease in special populations","volume":"18","author":"Jamerson","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2007.01.010_bib55","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 Report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193317110700040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193317110700040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T11:57:45Z","timestamp":1628942265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193317110700040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S193317110700040X"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2007.01.010","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}